forpressrelease Mail to a Friend
forpressrelease Rate forpressrelease forpressrelease forpressrelease forpressrelease forpressrelease 

Akcea Therapeutics Canada Confirms Letter of Intent with Pan-Canadian Pharmaceutical Alliance for TEGSEDI™



2024-04-21 05:44:06 Health and Fitness

857


Akcea Therapeutics Canada, Inc., a subsidiary of Akcea Therapeutics, Inc. (NASDAQ: AKCA), announced that it has concluded its negotiation with the pan-Canadian Pharmaceutical Alliance (pCPA) with a Letter of Intent regarding TEGSEDI? (inoterson) for the treatment of stage 1 or stage 2 polyneuropathy in adult patients with hereditary transthyretin amyloidosis (hATTR)1. Akcea Therapeutics, Inc. is a majority-owned affiliate of Ionis Pharmaceuticals, Inc.
For full article visit website.

Company :-Akcea Therapeutics Inc.

User :- Akcea Therapeutics

Email :-info.akceacanada@gmail.com

Url :- http://www.akceatx.ca/






Related Post

Advertisement